We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
+9.3%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$129M
AUM Growth
+$31M
Cap. Flow
+$24.2M
Cap. Flow %
18.73%
Top 10 Hldgs %
72.18%
Holding
83
New
11
Increased
21
Reduced
34
Closed
13

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$5.78M
2
ZBH icon
Zimmer Biomet
ZBH
+$5.47M
3
VYNE icon
VYNE Therapeutics
VYNE
+$1.73M
4
GENI icon
Genius Sports
GENI
+$674K
5
HYRE
HyreCar Inc. Common Stock
HYRE
+$594K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$5.43M
2
EHTH icon
eHealth
EHTH
+$1.66M
3
X
US Steel
X
+$769K
4
COMS
COMSovereign Holding Corp. Common Stock
COMS
+$725K
5
RTX icon
RTX Corp
RTX
+$284K

Sector Composition

Rank Sector Weight
1 Healthcare 32.19%
2 Technology 9.61%
3 Communication Services 9.37%
4 Financials 9.33%
5 Consumer Discretionary 2.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRM icon
26
Salesforce
CRM
$140B
$770K 0.59%
3,028
-119
-4% -$33.4K
PG icon
27
Procter & Gamble
PG
$349B
$753K 0.58%
4,601
-780
-14% -$116K
PYPL icon
28
PayPal
PYPL
$49.9B
$737K 0.57%
3,908
+360
+10% +$77.9K
HYRE
29
DELISTED
HyreCar Inc. Common Stock
HYRE
$542K 0.42%
115,000
+95,000
+475% +$594K
INTU icon
30
Intuit
INTU
$79.6B
$537K 0.41%
835
-61
-7% -$37.7K
JPM icon
31
JPMorgan Chase
JPM
$907B
$495K 0.38%
3,127
-338
-10% -$55.5K
CSCO icon
32
Cisco
CSCO
$441B
$476K 0.37%
7,515
+923
+14% +$52.7K
UNH icon
33
UnitedHealth
UNH
$387B
$473K 0.37%
941
-100
-10% -$45.3K
ORCL icon
34
Oracle
ORCL
$364B
$460K 0.36%
5,274
-986
-16% -$92.6K
PEP icon
35
PepsiCo
PEP
$187B
$455K 0.35%
2,617
-398
-13% -$65K
HD icon
36
Home Depot
HD
$338B
$447K 0.35%
1,076
-217
-17% -$82.6K
KO icon
37
Coca-Cola
KO
$351B
$441K 0.34%
7,441
-1,127
-13% -$62.8K
UNP icon
38
Union Pacific
UNP
$179B
$433K 0.33%
1,720
+261
+18% +$61.8K
UPS icon
39
United Parcel Service
UPS
$100B
$412K 0.32%
1,921
+350
+22% +$71.2K
IBM icon
40
IBM
IBM
$200B
$399K 0.31%
2,982
-344
-10% -$43.1K
NOW icon
41
ServiceNow
NOW
$106B
$397K 0.31%
3,060
-155
-5% -$20.4K
LIN icon
42
Linde
LIN
$237B
$381K 0.29%
1,101
-126
-10% -$40.8K
GENI icon
43
Genius Sports
GENI
$1.68B
$380K 0.29%
+50,000
New +$674K
HON icon
44
Honeywell
HON
$71.3B
$380K 0.29%
1,933
+325
+20% +$65.6K
JNJ icon
45
Johnson & Johnson
JNJ
$609B
$375K 0.29%
2,190
-80
-4% -$13.1K
AVGO icon
46
Broadcom
AVGO
$1.76T
$371K 0.29%
5,570
+860
+18% +$48.3K
QCOM icon
47
Qualcomm
QCOM
$181B
$368K 0.28%
2,010
+238
+13% +$38.1K
INTC icon
48
Intel
INTC
$478B
$354K 0.27%
6,866
+831
+14% +$42.5K
ADP icon
49
Automatic Data Processing
ADP
$102B
$347K 0.27%
1,406
-117
-8% -$26.5K
BAC icon
50
Bank of America
BAC
$430B
$345K 0.27%
7,746
-870
-10% -$39.6K
1
2
3 4

Similar funds

RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AG
Arctis Global San Juan, Puerto Rico $14.5M AUM 58.16% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KM
Kabouter Management Chicago, Illinois $15.6M AUM 16.79% 1-Year Est. Return

DSC Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, DSC Advisors held 83 positions worth $129M, up 31% from $98.5M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

DSC Advisors deployed $24.2M of net new capital in Q4 2021, opening 11 new positions and adding to 21 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 70,000 shares worth $6.18M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 32% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was eHealth, an estimated $1.66M trimmed.

  • DSC Advisors's largest Q4 2021 buy was BioMarin Pharmaceuticals: 70,000 shares worth $6.18M.
  • DSC Advisors added most to VYNE Therapeutics in Q4 2021, an estimated $1.73M increase.
  • DSC Advisors's biggest Q4 2021 reduction was eHealth, cutting an estimated $1.66M.
  • DSC Advisors fully exited Bristol-Myers Squibb in Q4 2021, selling an estimated $5.43M.
  • DSC Advisors's ten largest holdings make up 72% of its $129M portfolio in Q4 2021.
  • DSC Advisors opened 11 new positions and closed 13 in Q4 2021.
  • DSC Advisors's portfolio value rose 31% quarter-over-quarter to $129M.

Based on DSC Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.